> top > docs > PubMed:9639536 > annotations

PubMed:9639536 JSONTXT

Annnotations TAB JSON ListView MergeView

Glycan-Motif

Id Subject Object Predicate Lexical cue
T1 21-36 https://glytoucan.org/Structures/Glycans/G00054MO denotes sialyl Lewis(x)
T2 227-242 https://glytoucan.org/Structures/Glycans/G00054MO denotes sialyl Lewis(x)
T3 504-519 https://glytoucan.org/Structures/Glycans/G00054MO denotes sialyl Lewis(x)
T4 727-742 https://glytoucan.org/Structures/Glycans/G00054MO denotes sialyl Lewis(x)
T5 1130-1145 https://glytoucan.org/Structures/Glycans/G00054MO denotes sialyl Lewis(x)
T6 1365-1380 https://glytoucan.org/Structures/Glycans/G00054MO denotes sialyl Lewis(x)
T7 1468-1483 https://glytoucan.org/Structures/Glycans/G00054MO denotes sialyl Lewis(x)

GlyCosmos6-Glycan-Motif-Image

Id Subject Object Predicate Lexical cue image
T1 21-36 Glycan_Motif denotes sialyl Lewis(x) https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00054MO
T2 227-242 Glycan_Motif denotes sialyl Lewis(x) https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00054MO
T3 504-519 Glycan_Motif denotes sialyl Lewis(x) https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00054MO
T4 727-742 Glycan_Motif denotes sialyl Lewis(x) https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00054MO
T5 1130-1145 Glycan_Motif denotes sialyl Lewis(x) https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00054MO
T6 1365-1380 Glycan_Motif denotes sialyl Lewis(x) https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00054MO
T7 1468-1483 Glycan_Motif denotes sialyl Lewis(x) https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00054MO

Glycosmos6-GlycoEpitope

Id Subject Object Predicate Lexical cue
T1 21-36 http://www.glycoepitope.jp/epitopes/EP0012 denotes sialyl Lewis(x)
T2 227-242 http://www.glycoepitope.jp/epitopes/EP0012 denotes sialyl Lewis(x)
T3 504-519 http://www.glycoepitope.jp/epitopes/EP0012 denotes sialyl Lewis(x)
T4 727-742 http://www.glycoepitope.jp/epitopes/EP0012 denotes sialyl Lewis(x)
T5 1130-1145 http://www.glycoepitope.jp/epitopes/EP0012 denotes sialyl Lewis(x)
T6 1365-1380 http://www.glycoepitope.jp/epitopes/EP0012 denotes sialyl Lewis(x)
T7 1468-1483 http://www.glycoepitope.jp/epitopes/EP0012 denotes sialyl Lewis(x)

GlyCosmos6-Glycan-Motif-Structure

Id Subject Object Predicate Lexical cue
T1 21-36 https://glytoucan.org/Structures/Glycans/G00054MO denotes sialyl Lewis(x)
T2 227-242 https://glytoucan.org/Structures/Glycans/G00054MO denotes sialyl Lewis(x)
T3 504-519 https://glytoucan.org/Structures/Glycans/G00054MO denotes sialyl Lewis(x)
T4 727-742 https://glytoucan.org/Structures/Glycans/G00054MO denotes sialyl Lewis(x)
T5 1130-1145 https://glytoucan.org/Structures/Glycans/G00054MO denotes sialyl Lewis(x)
T6 1365-1380 https://glytoucan.org/Structures/Glycans/G00054MO denotes sialyl Lewis(x)
T7 1468-1483 https://glytoucan.org/Structures/Glycans/G00054MO denotes sialyl Lewis(x)

sentences

Id Subject Object Predicate Lexical cue
TextSentencer_T1 0-146 Sentence denotes Site localization of sialyl Lewis(x) antigen on alpha1-acid glycoprotein by high performance liquid chromatography-electrospray mass spectrometry.
TextSentencer_T2 147-279 Sentence denotes A simple, fast and sensitive method was developed to verify the presence of the sialyl Lewis(x) antigen on an N-linked glycoprotein.
TextSentencer_T3 280-528 Sentence denotes High performance liquid chromatography-electrospray mass spectrometry (HPLC-ESI/MS) was used to identify which of the five N-linked glycosylation sites of human plasma alpha1-acid-glycoprotein (orosomucoid, OMD) contain the sialyl Lewis(x) antigen.
TextSentencer_T4 529-645 Sentence denotes OMD was digested with proteolytic enzymes and analyzed by reversed phase chromatography coupled with on-line ESI/MS.
TextSentencer_T5 646-885 Sentence denotes A tandem mass spectrometry experiment was designed to detect the presence of the sialyl Lewis(x) antigen based on the observation of an 803 mass to charge ratio ( m/z ) ion produced in the intermediate pressure region of the ESI interface.
TextSentencer_T6 886-1011 Sentence denotes The ESI/MS signal at m/z 803 is consistent with an oxonium ion for a glycan structure containing NeuAc, Gal, GlcNAc, and Fuc.
TextSentencer_T7 1012-1155 Sentence denotes The identity of the m/z 803 ion was confirmed by ESI/MS/MS analysis of the m/z 803 fragment ion and comparison with a sialyl Lewis(x) standard.
TextSentencer_T8 1156-1306 Sentence denotes The stereochemistry and linkage positions were assigned using previous NMR analysis but could be determined with permethylation analysis if necessary.
TextSentencer_T9 1307-1444 Sentence denotes The analysis of OMD gave a pattern showing signal for the sialyl Lewis(x) antigen coeluting with each of the five N-linked glycopeptides.
TextSentencer_T10 1445-1588 Sentence denotes The ability to monitor sialyl Lewis(x) expression at each of the five sites is of interest in the study of OMD's role in inflammatory diseases.
T1 0-146 Sentence denotes Site localization of sialyl Lewis(x) antigen on alpha1-acid glycoprotein by high performance liquid chromatography-electrospray mass spectrometry.
T2 147-279 Sentence denotes A simple, fast and sensitive method was developed to verify the presence of the sialyl Lewis(x) antigen on an N-linked glycoprotein.
T3 280-528 Sentence denotes High performance liquid chromatography-electrospray mass spectrometry (HPLC-ESI/MS) was used to identify which of the five N-linked glycosylation sites of human plasma alpha1-acid-glycoprotein (orosomucoid, OMD) contain the sialyl Lewis(x) antigen.
T4 529-645 Sentence denotes OMD was digested with proteolytic enzymes and analyzed by reversed phase chromatography coupled with on-line ESI/MS.
T5 646-885 Sentence denotes A tandem mass spectrometry experiment was designed to detect the presence of the sialyl Lewis(x) antigen based on the observation of an 803 mass to charge ratio ( m/z ) ion produced in the intermediate pressure region of the ESI interface.
T6 886-1155 Sentence denotes The ESI/MS signal at m/z 803 is consistent with an oxonium ion for a glycan structure containing NeuAc, Gal, GlcNAc, and Fuc. The identity of the m/z 803 ion was confirmed by ESI/MS/MS analysis of the m/z 803 fragment ion and comparison with a sialyl Lewis(x) standard.
T7 1156-1306 Sentence denotes The stereochemistry and linkage positions were assigned using previous NMR analysis but could be determined with permethylation analysis if necessary.
T8 1307-1444 Sentence denotes The analysis of OMD gave a pattern showing signal for the sialyl Lewis(x) antigen coeluting with each of the five N-linked glycopeptides.
T9 1445-1588 Sentence denotes The ability to monitor sialyl Lewis(x) expression at each of the five sites is of interest in the study of OMD's role in inflammatory diseases.
T1 0-146 Sentence denotes Site localization of sialyl Lewis(x) antigen on alpha1-acid glycoprotein by high performance liquid chromatography-electrospray mass spectrometry.
T2 147-279 Sentence denotes A simple, fast and sensitive method was developed to verify the presence of the sialyl Lewis(x) antigen on an N-linked glycoprotein.
T3 280-528 Sentence denotes High performance liquid chromatography-electrospray mass spectrometry (HPLC-ESI/MS) was used to identify which of the five N-linked glycosylation sites of human plasma alpha1-acid-glycoprotein (orosomucoid, OMD) contain the sialyl Lewis(x) antigen.
T4 529-645 Sentence denotes OMD was digested with proteolytic enzymes and analyzed by reversed phase chromatography coupled with on-line ESI/MS.
T5 646-885 Sentence denotes A tandem mass spectrometry experiment was designed to detect the presence of the sialyl Lewis(x) antigen based on the observation of an 803 mass to charge ratio ( m/z ) ion produced in the intermediate pressure region of the ESI interface.
T6 886-1011 Sentence denotes The ESI/MS signal at m/z 803 is consistent with an oxonium ion for a glycan structure containing NeuAc, Gal, GlcNAc, and Fuc.
T7 1012-1155 Sentence denotes The identity of the m/z 803 ion was confirmed by ESI/MS/MS analysis of the m/z 803 fragment ion and comparison with a sialyl Lewis(x) standard.
T8 1156-1306 Sentence denotes The stereochemistry and linkage positions were assigned using previous NMR analysis but could be determined with permethylation analysis if necessary.
T9 1307-1444 Sentence denotes The analysis of OMD gave a pattern showing signal for the sialyl Lewis(x) antigen coeluting with each of the five N-linked glycopeptides.
T10 1445-1588 Sentence denotes The ability to monitor sialyl Lewis(x) expression at each of the five sites is of interest in the study of OMD's role in inflammatory diseases.

GlycoBiology-FMA

Id Subject Object Predicate Lexical cue
_T1 60-72 FMAID:62925 denotes glycoprotein
_T2 60-72 FMAID:167256 denotes glycoprotein
_T3 93-99 FMAID:85815 denotes liquid
_T4 266-278 FMAID:167256 denotes glycoprotein
_T5 266-278 FMAID:62925 denotes glycoprotein
_T6 297-303 FMAID:85815 denotes liquid
_T7 441-447 FMAID:162307 denotes plasma
_T8 460-472 FMAID:167256 denotes glycoprotein
_T9 460-472 FMAID:62925 denotes glycoprotein
_T10 835-847 FMAID:179268 denotes intermediate
_T11 835-847 FMAID:74531 denotes intermediate
_T12 1430-1443 FMAID:196778 denotes glycopeptides
_T13 1430-1443 FMAID:82784 denotes glycopeptides

uniprot-human

Id Subject Object Predicate Lexical cue
T1 356-359 http://www.uniprot.org/uniprot/P19957 denotes ESI
T2 638-641 http://www.uniprot.org/uniprot/P19957 denotes ESI
T3 871-874 http://www.uniprot.org/uniprot/P19957 denotes ESI
T4 890-893 http://www.uniprot.org/uniprot/P19957 denotes ESI
T5 1061-1064 http://www.uniprot.org/uniprot/P19957 denotes ESI
T6 360-362 http://www.uniprot.org/uniprot/Q99707 denotes MS
T7 642-644 http://www.uniprot.org/uniprot/Q99707 denotes MS
T8 894-896 http://www.uniprot.org/uniprot/Q99707 denotes MS
T9 1065-1067 http://www.uniprot.org/uniprot/Q99707 denotes MS
T10 1068-1070 http://www.uniprot.org/uniprot/Q99707 denotes MS
T11 487-490 http://www.uniprot.org/uniprot/Q99983 denotes OMD
T12 529-532 http://www.uniprot.org/uniprot/Q99983 denotes OMD
T13 1323-1326 http://www.uniprot.org/uniprot/Q99983 denotes OMD

uniprot-mouse

Id Subject Object Predicate Lexical cue
T1 360-362 http://www.uniprot.org/uniprot/A6H5Y3 denotes MS
T2 642-644 http://www.uniprot.org/uniprot/A6H5Y3 denotes MS
T3 894-896 http://www.uniprot.org/uniprot/A6H5Y3 denotes MS
T4 1065-1067 http://www.uniprot.org/uniprot/A6H5Y3 denotes MS
T5 1068-1070 http://www.uniprot.org/uniprot/A6H5Y3 denotes MS

GO-BP

Id Subject Object Predicate Lexical cue
T1 5-17 http://purl.obolibrary.org/obo/GO_0051179 denotes localization
T2 21-27 http://purl.obolibrary.org/obo/GO_0097503 denotes sialyl
T3 227-233 http://purl.obolibrary.org/obo/GO_0097503 denotes sialyl
T4 504-510 http://purl.obolibrary.org/obo/GO_0097503 denotes sialyl
T5 727-733 http://purl.obolibrary.org/obo/GO_0097503 denotes sialyl
T6 1130-1136 http://purl.obolibrary.org/obo/GO_0097503 denotes sialyl
T7 1365-1371 http://purl.obolibrary.org/obo/GO_0097503 denotes sialyl
T8 1468-1474 http://purl.obolibrary.org/obo/GO_0097503 denotes sialyl
T9 157-161 http://purl.obolibrary.org/obo/GO_0033867 denotes fast
T10 166-175 http://purl.obolibrary.org/obo/GO_0046960 denotes sensitive
T11 187-196 http://purl.obolibrary.org/obo/GO_0032502 denotes developed
T12 403-425 http://purl.obolibrary.org/obo/GO_0006487 denotes N-linked glycosylation
T13 412-425 http://purl.obolibrary.org/obo/GO_0070085 denotes glycosylation
T14 537-545 http://purl.obolibrary.org/obo/GO_0007586 denotes digested
T15 897-903 http://purl.obolibrary.org/obo/GO_0023052 denotes signal
T16 1350-1356 http://purl.obolibrary.org/obo/GO_0023052 denotes signal

NGLY1-deficiency

Id Subject Object Predicate Lexical cue
PD-NGLY1-deficiency-B_T1 995-1001 chem:24139 denotes GlcNAc
T1 995-1001 chem:24139 denotes GlcNAc

GlycoBiology-Motifs

Id Subject Object Predicate Lexical cue
T1 21-33 http://rdf.glycoinfo.org/glycan/G00053MO denotes sialyl Lewis
T2 227-239 http://rdf.glycoinfo.org/glycan/G00053MO denotes sialyl Lewis
T3 504-516 http://rdf.glycoinfo.org/glycan/G00053MO denotes sialyl Lewis
T4 727-739 http://rdf.glycoinfo.org/glycan/G00053MO denotes sialyl Lewis
T5 1130-1142 http://rdf.glycoinfo.org/glycan/G00053MO denotes sialyl Lewis
T6 1365-1377 http://rdf.glycoinfo.org/glycan/G00053MO denotes sialyl Lewis
T7 1468-1480 http://rdf.glycoinfo.org/glycan/G00053MO denotes sialyl Lewis
T8 21-35 http://rdf.glycoinfo.org/glycan/G00054MO denotes sialyl Lewis(x
T9 227-241 http://rdf.glycoinfo.org/glycan/G00054MO denotes sialyl Lewis(x
T10 504-518 http://rdf.glycoinfo.org/glycan/G00054MO denotes sialyl Lewis(x
T11 727-741 http://rdf.glycoinfo.org/glycan/G00054MO denotes sialyl Lewis(x
T12 1130-1144 http://rdf.glycoinfo.org/glycan/G00054MO denotes sialyl Lewis(x
T13 1365-1379 http://rdf.glycoinfo.org/glycan/G00054MO denotes sialyl Lewis(x
T14 1468-1482 http://rdf.glycoinfo.org/glycan/G00054MO denotes sialyl Lewis(x
T15 28-33 http://rdf.glycoinfo.org/glycan/G00047MO denotes Lewis
T16 234-239 http://rdf.glycoinfo.org/glycan/G00047MO denotes Lewis
T17 511-516 http://rdf.glycoinfo.org/glycan/G00047MO denotes Lewis
T18 734-739 http://rdf.glycoinfo.org/glycan/G00047MO denotes Lewis
T19 1137-1142 http://rdf.glycoinfo.org/glycan/G00047MO denotes Lewis
T20 1372-1377 http://rdf.glycoinfo.org/glycan/G00047MO denotes Lewis
T21 1475-1480 http://rdf.glycoinfo.org/glycan/G00047MO denotes Lewis
T22 28-35 http://rdf.glycoinfo.org/glycan/G00051MO denotes Lewis(x
T23 234-241 http://rdf.glycoinfo.org/glycan/G00051MO denotes Lewis(x
T24 511-518 http://rdf.glycoinfo.org/glycan/G00051MO denotes Lewis(x
T25 734-741 http://rdf.glycoinfo.org/glycan/G00051MO denotes Lewis(x
T26 1137-1144 http://rdf.glycoinfo.org/glycan/G00051MO denotes Lewis(x
T27 1372-1379 http://rdf.glycoinfo.org/glycan/G00051MO denotes Lewis(x
T28 1475-1482 http://rdf.glycoinfo.org/glycan/G00051MO denotes Lewis(x

GlycoBiology-Epitope

Id Subject Object Predicate Lexical cue
PD-GlycoEpitope-B_T1 28-35 http://www.glycoepitope.jp/epitopes/EP0011 denotes Lewis(x
PD-GlycoEpitope-B_T2 234-241 http://www.glycoepitope.jp/epitopes/EP0011 denotes Lewis(x
PD-GlycoEpitope-B_T3 511-518 http://www.glycoepitope.jp/epitopes/EP0011 denotes Lewis(x
PD-GlycoEpitope-B_T4 734-741 http://www.glycoepitope.jp/epitopes/EP0011 denotes Lewis(x
PD-GlycoEpitope-B_T5 1137-1144 http://www.glycoepitope.jp/epitopes/EP0011 denotes Lewis(x
PD-GlycoEpitope-B_T6 1372-1379 http://www.glycoepitope.jp/epitopes/EP0011 denotes Lewis(x
PD-GlycoEpitope-B_T7 1475-1482 http://www.glycoepitope.jp/epitopes/EP0011 denotes Lewis(x
PD-GlycoEpitope-B_T8 21-33 http://www.glycoepitope.jp/epitopes/EP0008 denotes sialyl Lewis
PD-GlycoEpitope-B_T9 227-239 http://www.glycoepitope.jp/epitopes/EP0008 denotes sialyl Lewis
PD-GlycoEpitope-B_T10 504-516 http://www.glycoepitope.jp/epitopes/EP0008 denotes sialyl Lewis
PD-GlycoEpitope-B_T11 727-739 http://www.glycoepitope.jp/epitopes/EP0008 denotes sialyl Lewis
PD-GlycoEpitope-B_T12 1130-1142 http://www.glycoepitope.jp/epitopes/EP0008 denotes sialyl Lewis
PD-GlycoEpitope-B_T13 1365-1377 http://www.glycoepitope.jp/epitopes/EP0008 denotes sialyl Lewis
PD-GlycoEpitope-B_T14 1468-1480 http://www.glycoepitope.jp/epitopes/EP0008 denotes sialyl Lewis
PD-GlycoEpitope-B_T15 21-35 http://www.glycoepitope.jp/epitopes/EP0012 denotes sialyl Lewis(x
PD-GlycoEpitope-B_T16 227-241 http://www.glycoepitope.jp/epitopes/EP0012 denotes sialyl Lewis(x
PD-GlycoEpitope-B_T17 504-518 http://www.glycoepitope.jp/epitopes/EP0012 denotes sialyl Lewis(x
PD-GlycoEpitope-B_T18 727-741 http://www.glycoepitope.jp/epitopes/EP0012 denotes sialyl Lewis(x
PD-GlycoEpitope-B_T19 1130-1144 http://www.glycoepitope.jp/epitopes/EP0012 denotes sialyl Lewis(x
PD-GlycoEpitope-B_T20 1365-1379 http://www.glycoepitope.jp/epitopes/EP0012 denotes sialyl Lewis(x
PD-GlycoEpitope-B_T21 1468-1482 http://www.glycoepitope.jp/epitopes/EP0012 denotes sialyl Lewis(x

GlyTouCan-IUPAC

Id Subject Object Predicate Lexical cue
GlycanIUPAC_T1 990-993 "http://rdf.glycoinfo.org/glycan/G93924TT" denotes Gal
GlycanIUPAC_T2 990-993 "http://rdf.glycoinfo.org/glycan/G25565DN" denotes Gal
GlycanIUPAC_T3 990-993 "http://rdf.glycoinfo.org/glycan/G97215EV" denotes Gal
GlycanIUPAC_T4 990-993 "http://rdf.glycoinfo.org/glycan/G79664KO" denotes Gal
GlycanIUPAC_T5 990-993 "http://rdf.glycoinfo.org/glycan/G24107FU" denotes Gal
GlycanIUPAC_T6 990-993 "http://rdf.glycoinfo.org/glycan/G09864UE" denotes Gal
GlycanIUPAC_T7 990-993 "http://rdf.glycoinfo.org/glycan/G28032MC" denotes Gal
GlycanIUPAC_T8 990-993 "http://rdf.glycoinfo.org/glycan/G28005UP" denotes Gal
GlycanIUPAC_T9 990-993 "http://rdf.glycoinfo.org/glycan/G92708AT" denotes Gal
GlycanIUPAC_T10 990-993 "http://rdf.glycoinfo.org/glycan/G73757UC" denotes Gal
GlycanIUPAC_T11 990-993 "http://rdf.glycoinfo.org/glycan/G51062DM" denotes Gal
GlycanIUPAC_T12 990-993 "http://rdf.glycoinfo.org/glycan/G05866BJ" denotes Gal
GlycanIUPAC_T13 990-993 "http://rdf.glycoinfo.org/glycan/G87394FZ" denotes Gal
GlycanIUPAC_T14 990-993 "http://rdf.glycoinfo.org/glycan/G03871NF" denotes Gal
GlycanIUPAC_T15 990-993 "http://rdf.glycoinfo.org/glycan/G29377VE" denotes Gal
GlycanIUPAC_T16 990-993 "http://rdf.glycoinfo.org/glycan/G33457CX" denotes Gal
GlycanIUPAC_T17 990-993 "http://rdf.glycoinfo.org/glycan/G97368GU" denotes Gal
GlycanIUPAC_T18 990-993 "http://rdf.glycoinfo.org/glycan/G18512EL" denotes Gal
GlycanIUPAC_T19 990-993 "http://rdf.glycoinfo.org/glycan/G41137VS" denotes Gal
GlycanIUPAC_T20 990-993 "http://rdf.glycoinfo.org/glycan/G30521NA" denotes Gal
GlycanIUPAC_T21 990-993 "http://rdf.glycoinfo.org/glycan/G19388CD" denotes Gal
GlycanIUPAC_T22 990-993 "http://rdf.glycoinfo.org/glycan/G53151FU" denotes Gal
GlycanIUPAC_T23 990-993 "http://rdf.glycoinfo.org/glycan/G27105XC" denotes Gal
GlycanIUPAC_T24 990-993 "http://rdf.glycoinfo.org/glycan/G91210VM" denotes Gal
GlycanIUPAC_T25 990-993 "http://rdf.glycoinfo.org/glycan/G40841DE" denotes Gal
GlycanIUPAC_T26 990-993 "http://rdf.glycoinfo.org/glycan/G71241HP" denotes Gal
GlycanIUPAC_T27 990-993 "http://rdf.glycoinfo.org/glycan/G84636BJ" denotes Gal
GlycanIUPAC_T28 990-993 "http://rdf.glycoinfo.org/glycan/G47905LJ" denotes Gal
GlycanIUPAC_T29 990-993 "http://rdf.glycoinfo.org/glycan/G39340DV" denotes Gal
GlycanIUPAC_T30 990-993 "http://rdf.glycoinfo.org/glycan/G48801AQ" denotes Gal
GlycanIUPAC_T31 990-993 "http://rdf.glycoinfo.org/glycan/G14573NX" denotes Gal
GlycanIUPAC_T32 990-993 "http://rdf.glycoinfo.org/glycan/G56762TR" denotes Gal
GlycanIUPAC_T33 990-993 "http://rdf.glycoinfo.org/glycan/G20013XO" denotes Gal
GlycanIUPAC_T34 990-993 "http://rdf.glycoinfo.org/glycan/G39504DR" denotes Gal
GlycanIUPAC_T35 990-993 "http://rdf.glycoinfo.org/glycan/G35218RQ" denotes Gal
GlycanIUPAC_T36 990-993 "http://rdf.glycoinfo.org/glycan/G53048SH" denotes Gal
GlycanIUPAC_T37 990-993 "http://rdf.glycoinfo.org/glycan/G78418IX" denotes Gal
GlycanIUPAC_T38 990-993 "http://rdf.glycoinfo.org/glycan/G09780OD" denotes Gal
GlycanIUPAC_T39 990-993 "http://rdf.glycoinfo.org/glycan/G56359GL" denotes Gal
GlycanIUPAC_T40 990-993 "http://rdf.glycoinfo.org/glycan/G78941YC" denotes Gal
GlycanIUPAC_T41 990-993 "http://rdf.glycoinfo.org/glycan/G26829FC" denotes Gal
GlycanIUPAC_T42 990-993 "http://rdf.glycoinfo.org/glycan/G88538ZC" denotes Gal
GlycanIUPAC_T43 990-993 "http://rdf.glycoinfo.org/glycan/G46593ZR" denotes Gal
GlycanIUPAC_T44 990-993 "http://rdf.glycoinfo.org/glycan/G43523TH" denotes Gal
GlycanIUPAC_T45 990-993 "http://rdf.glycoinfo.org/glycan/G36445ON" denotes Gal
GlycanIUPAC_T46 990-993 "http://rdf.glycoinfo.org/glycan/G67363FK" denotes Gal
GlycanIUPAC_T47 990-993 "http://rdf.glycoinfo.org/glycan/G17562KT" denotes Gal
GlycanIUPAC_T48 990-993 "http://rdf.glycoinfo.org/glycan/G24774YJ" denotes Gal
GlycanIUPAC_T49 990-993 "http://rdf.glycoinfo.org/glycan/G32162UO" denotes Gal
GlycanIUPAC_T50 990-993 "http://rdf.glycoinfo.org/glycan/G89163RR" denotes Gal
GlycanIUPAC_T51 990-993 "http://rdf.glycoinfo.org/glycan/G99522DY" denotes Gal
GlycanIUPAC_T52 990-993 "http://rdf.glycoinfo.org/glycan/G59246IF" denotes Gal
GlycanIUPAC_T53 990-993 "http://rdf.glycoinfo.org/glycan/G95321NT" denotes Gal
GlycanIUPAC_T54 990-993 "http://rdf.glycoinfo.org/glycan/G17531ZI" denotes Gal
GlycanIUPAC_T55 990-993 "http://rdf.glycoinfo.org/glycan/G54322SU" denotes Gal
GlycanIUPAC_T56 990-993 "http://rdf.glycoinfo.org/glycan/G72010DO" denotes Gal
GlycanIUPAC_T57 990-993 "http://rdf.glycoinfo.org/glycan/G44269EP" denotes Gal
GlycanIUPAC_T58 990-993 "http://rdf.glycoinfo.org/glycan/G57335AD" denotes Gal
GlycanIUPAC_T59 990-993 "http://rdf.glycoinfo.org/glycan/G60837LL" denotes Gal
GlycanIUPAC_T60 990-993 "http://rdf.glycoinfo.org/glycan/G61929XX" denotes Gal
GlycanIUPAC_T61 990-993 "http://rdf.glycoinfo.org/glycan/G88747RA" denotes Gal
GlycanIUPAC_T62 990-993 "http://rdf.glycoinfo.org/glycan/G47955HA" denotes Gal
GlycanIUPAC_T63 990-993 "http://rdf.glycoinfo.org/glycan/G60982WS" denotes Gal
GlycanIUPAC_T64 990-993 "http://rdf.glycoinfo.org/glycan/G37035KG" denotes Gal
GlycanIUPAC_T65 990-993 "http://rdf.glycoinfo.org/glycan/G46297FI" denotes Gal
GlycanIUPAC_T66 990-993 "http://rdf.glycoinfo.org/glycan/G35475KI" denotes Gal
GlycanIUPAC_T67 990-993 "http://rdf.glycoinfo.org/glycan/G29771JN" denotes Gal
GlycanIUPAC_T68 990-993 "http://rdf.glycoinfo.org/glycan/G61285YR" denotes Gal
GlycanIUPAC_T69 990-993 "http://rdf.glycoinfo.org/glycan/G54785MW" denotes Gal
GlycanIUPAC_T70 990-993 "http://rdf.glycoinfo.org/glycan/G53039GT" denotes Gal
GlycanIUPAC_T71 990-993 "http://rdf.glycoinfo.org/glycan/G00601HK" denotes Gal
GlycanIUPAC_T72 990-993 "http://rdf.glycoinfo.org/glycan/G10485IJ" denotes Gal
GlycanIUPAC_T73 990-993 "http://rdf.glycoinfo.org/glycan/G16393IB" denotes Gal
GlycanIUPAC_T74 990-993 "http://rdf.glycoinfo.org/glycan/G98436FZ" denotes Gal
GlycanIUPAC_T75 990-993 "http://rdf.glycoinfo.org/glycan/G18825IA" denotes Gal
GlycanIUPAC_T76 990-993 "http://rdf.glycoinfo.org/glycan/G61281HQ" denotes Gal
GlycanIUPAC_T77 990-993 "http://rdf.glycoinfo.org/glycan/G07798TI" denotes Gal
GlycanIUPAC_T78 990-993 "http://rdf.glycoinfo.org/glycan/G55921QA" denotes Gal
GlycanIUPAC_T79 990-993 "http://rdf.glycoinfo.org/glycan/G99066DL" denotes Gal
GlycanIUPAC_T80 990-993 "http://rdf.glycoinfo.org/glycan/G33451PQ" denotes Gal
GlycanIUPAC_T81 990-993 "http://rdf.glycoinfo.org/glycan/G02111XU" denotes Gal
GlycanIUPAC_T82 990-993 "http://rdf.glycoinfo.org/glycan/G85193OM" denotes Gal
GlycanIUPAC_T83 990-993 "http://rdf.glycoinfo.org/glycan/G89174YQ" denotes Gal
GlycanIUPAC_T84 990-993 "http://rdf.glycoinfo.org/glycan/G28802LE" denotes Gal
GlycanIUPAC_T85 990-993 "http://rdf.glycoinfo.org/glycan/G56061JK" denotes Gal
GlycanIUPAC_T86 990-993 "http://rdf.glycoinfo.org/glycan/G68941BC" denotes Gal
GlycanIUPAC_T87 990-993 "http://rdf.glycoinfo.org/glycan/G55436FC" denotes Gal
GlycanIUPAC_T88 990-993 "http://rdf.glycoinfo.org/glycan/G24002PU" denotes Gal
GlycanIUPAC_T89 990-993 "http://rdf.glycoinfo.org/glycan/G61387SV" denotes Gal
GlycanIUPAC_T90 990-993 "http://rdf.glycoinfo.org/glycan/G31834HW" denotes Gal
GlycanIUPAC_T91 990-993 "http://rdf.glycoinfo.org/glycan/G35324RT" denotes Gal
GlycanIUPAC_T92 990-993 "http://rdf.glycoinfo.org/glycan/G34803QO" denotes Gal
GlycanIUPAC_T93 990-993 "http://rdf.glycoinfo.org/glycan/G92898FF" denotes Gal
GlycanIUPAC_T94 990-993 "http://rdf.glycoinfo.org/glycan/G01318VX" denotes Gal
GlycanIUPAC_T95 990-993 "http://rdf.glycoinfo.org/glycan/G83200MX" denotes Gal
GlycanIUPAC_T96 990-993 "http://rdf.glycoinfo.org/glycan/G56286UC" denotes Gal
GlycanIUPAC_T97 990-993 "http://rdf.glycoinfo.org/glycan/G07304QA" denotes Gal
GlycanIUPAC_T98 990-993 "http://rdf.glycoinfo.org/glycan/G06868OU" denotes Gal
GlycanIUPAC_T99 990-993 "http://rdf.glycoinfo.org/glycan/G12647BS" denotes Gal
GlycanIUPAC_T100 990-993 "http://rdf.glycoinfo.org/glycan/G51841DF" denotes Gal
GlycanIUPAC_T101 990-993 "http://rdf.glycoinfo.org/glycan/G32122AJ" denotes Gal
GlycanIUPAC_T102 990-993 "http://rdf.glycoinfo.org/glycan/G41125MN" denotes Gal
GlycanIUPAC_T103 990-993 "http://rdf.glycoinfo.org/glycan/G16093XS" denotes Gal
GlycanIUPAC_T104 990-993 "http://rdf.glycoinfo.org/glycan/G62425IX" denotes Gal
GlycanIUPAC_T105 990-993 "http://rdf.glycoinfo.org/glycan/G15673TO" denotes Gal
GlycanIUPAC_T106 990-993 "http://rdf.glycoinfo.org/glycan/G32857IK" denotes Gal
GlycanIUPAC_T107 990-993 "http://rdf.glycoinfo.org/glycan/G60047CJ" denotes Gal
GlycanIUPAC_T108 990-993 "http://rdf.glycoinfo.org/glycan/G55718ZB" denotes Gal
GlycanIUPAC_T109 990-993 "http://rdf.glycoinfo.org/glycan/G88355ZE" denotes Gal
GlycanIUPAC_T110 990-993 "http://rdf.glycoinfo.org/glycan/G11283PA" denotes Gal
GlycanIUPAC_T111 990-993 "http://rdf.glycoinfo.org/glycan/G71737IZ" denotes Gal
GlycanIUPAC_T112 990-993 "http://rdf.glycoinfo.org/glycan/G60912WZ" denotes Gal
GlycanIUPAC_T113 990-993 "http://rdf.glycoinfo.org/glycan/G99655SO" denotes Gal
GlycanIUPAC_T114 990-993 "http://rdf.glycoinfo.org/glycan/G10300TW" denotes Gal
GlycanIUPAC_T115 990-993 "http://rdf.glycoinfo.org/glycan/G89509FL" denotes Gal
GlycanIUPAC_T116 990-993 "http://rdf.glycoinfo.org/glycan/G31465TH" denotes Gal
GlycanIUPAC_T117 990-993 "http://rdf.glycoinfo.org/glycan/G94101LU" denotes Gal
GlycanIUPAC_T118 990-993 "http://rdf.glycoinfo.org/glycan/G38610BB" denotes Gal
GlycanIUPAC_T119 990-993 "http://rdf.glycoinfo.org/glycan/G85893UF" denotes Gal
GlycanIUPAC_T120 990-1001 "http://rdf.glycoinfo.org/glycan/G23119WX" denotes Gal, GlcNAc
GlycanIUPAC_T121 990-1001 "http://rdf.glycoinfo.org/glycan/G62403LO" denotes Gal, GlcNAc
GlycanIUPAC_T122 990-1001 "http://rdf.glycoinfo.org/glycan/G52042RO" denotes Gal, GlcNAc
GlycanIUPAC_T123 990-1001 "http://rdf.glycoinfo.org/glycan/G86411PT" denotes Gal, GlcNAc
GlycanIUPAC_T124 990-1001 "http://rdf.glycoinfo.org/glycan/G80663AU" denotes Gal, GlcNAc
GlycanIUPAC_T125 990-1001 "http://rdf.glycoinfo.org/glycan/G55644UC" denotes Gal, GlcNAc
GlycanIUPAC_T126 990-1001 "http://rdf.glycoinfo.org/glycan/G81556FU" denotes Gal, GlcNAc
GlycanIUPAC_T127 990-1001 "http://rdf.glycoinfo.org/glycan/G02452VK" denotes Gal, GlcNAc
GlycanIUPAC_T128 990-1001 "http://rdf.glycoinfo.org/glycan/G66219IC" denotes Gal, GlcNAc
GlycanIUPAC_T129 990-1001 "http://rdf.glycoinfo.org/glycan/G53328JP" denotes Gal, GlcNAc
GlycanIUPAC_T130 995-1001 "http://rdf.glycoinfo.org/glycan/G26693XF" denotes GlcNAc
GlycanIUPAC_T131 995-1001 "http://rdf.glycoinfo.org/glycan/G01864SU" denotes GlcNAc
GlycanIUPAC_T132 995-1001 "http://rdf.glycoinfo.org/glycan/G17605FD" denotes GlcNAc
GlycanIUPAC_T133 995-1001 "http://rdf.glycoinfo.org/glycan/G41950LU" denotes GlcNAc
GlycanIUPAC_T134 995-1001 "http://rdf.glycoinfo.org/glycan/G57195RJ" denotes GlcNAc
GlycanIUPAC_T135 995-1001 "http://rdf.glycoinfo.org/glycan/G85391SA" denotes GlcNAc
GlycanIUPAC_T136 995-1001 "http://rdf.glycoinfo.org/glycan/G89565QL" denotes GlcNAc
GlycanIUPAC_T137 995-1001 "http://rdf.glycoinfo.org/glycan/G80869MR" denotes GlcNAc
GlycanIUPAC_T138 995-1001 "http://rdf.glycoinfo.org/glycan/G55978NL" denotes GlcNAc
GlycanIUPAC_T139 995-1001 "http://rdf.glycoinfo.org/glycan/G54644LT" denotes GlcNAc
GlycanIUPAC_T140 995-1001 "http://rdf.glycoinfo.org/glycan/G25694UG" denotes GlcNAc
GlycanIUPAC_T141 995-1001 "http://rdf.glycoinfo.org/glycan/G25126RB" denotes GlcNAc
GlycanIUPAC_T142 995-1001 "http://rdf.glycoinfo.org/glycan/G51848AD" denotes GlcNAc
GlycanIUPAC_T143 995-1001 "http://rdf.glycoinfo.org/glycan/G94667GM" denotes GlcNAc
GlycanIUPAC_T144 995-1001 "http://rdf.glycoinfo.org/glycan/G30124BO" denotes GlcNAc
GlycanIUPAC_T145 995-1001 "http://rdf.glycoinfo.org/glycan/G82777EZ" denotes GlcNAc
GlycanIUPAC_T146 995-1001 "http://rdf.glycoinfo.org/glycan/G10151YZ" denotes GlcNAc
GlycanIUPAC_T147 995-1001 "http://rdf.glycoinfo.org/glycan/G17585ZM" denotes GlcNAc
GlycanIUPAC_T148 995-1001 "http://rdf.glycoinfo.org/glycan/G04411CJ" denotes GlcNAc
GlycanIUPAC_T149 995-1001 "http://rdf.glycoinfo.org/glycan/G38254HJ" denotes GlcNAc
GlycanIUPAC_T150 995-1001 "http://rdf.glycoinfo.org/glycan/G75188FS" denotes GlcNAc
GlycanIUPAC_T151 995-1001 "http://rdf.glycoinfo.org/glycan/G70374VG" denotes GlcNAc
GlycanIUPAC_T152 995-1001 "http://rdf.glycoinfo.org/glycan/G45176LJ" denotes GlcNAc
GlycanIUPAC_T153 995-1001 "http://rdf.glycoinfo.org/glycan/G30874VW" denotes GlcNAc
GlycanIUPAC_T154 995-1001 "http://rdf.glycoinfo.org/glycan/G69333MI" denotes GlcNAc
GlycanIUPAC_T155 995-1001 "http://rdf.glycoinfo.org/glycan/G10676XO" denotes GlcNAc
GlycanIUPAC_T156 995-1001 "http://rdf.glycoinfo.org/glycan/G14843DJ" denotes GlcNAc
GlycanIUPAC_T157 995-1001 "http://rdf.glycoinfo.org/glycan/G47546FR" denotes GlcNAc
GlycanIUPAC_T158 995-1001 "http://rdf.glycoinfo.org/glycan/G73695ZM" denotes GlcNAc
GlycanIUPAC_T159 995-1001 "http://rdf.glycoinfo.org/glycan/G31923TJ" denotes GlcNAc
GlycanIUPAC_T160 995-1001 "http://rdf.glycoinfo.org/glycan/G60519EP" denotes GlcNAc
GlycanIUPAC_T161 995-1001 "http://rdf.glycoinfo.org/glycan/G07933IA" denotes GlcNAc
GlycanIUPAC_T162 995-1001 "http://rdf.glycoinfo.org/glycan/G40745NH" denotes GlcNAc
GlycanIUPAC_T163 995-1001 "http://rdf.glycoinfo.org/glycan/G54496YV" denotes GlcNAc
GlycanIUPAC_T164 995-1001 "http://rdf.glycoinfo.org/glycan/G62953SQ" denotes GlcNAc
GlycanIUPAC_T165 995-1001 "http://rdf.glycoinfo.org/glycan/G70070AY" denotes GlcNAc
GlycanIUPAC_T166 995-1001 "http://rdf.glycoinfo.org/glycan/G78792WC" denotes GlcNAc
GlycanIUPAC_T167 995-1001 "http://rdf.glycoinfo.org/glycan/G25238AV" denotes GlcNAc
GlycanIUPAC_T168 995-1001 "http://rdf.glycoinfo.org/glycan/G40510DP" denotes GlcNAc
GlycanIUPAC_T169 995-1001 "http://rdf.glycoinfo.org/glycan/G61120TK" denotes GlcNAc
GlycanIUPAC_T170 995-1001 "http://rdf.glycoinfo.org/glycan/G41342KV" denotes GlcNAc
GlycanIUPAC_T171 995-1001 "http://rdf.glycoinfo.org/glycan/G90703NA" denotes GlcNAc
GlycanIUPAC_T172 995-1001 "http://rdf.glycoinfo.org/glycan/G01591HR" denotes GlcNAc
GlycanIUPAC_T173 995-1001 "http://rdf.glycoinfo.org/glycan/G56520XN" denotes GlcNAc
GlycanIUPAC_T174 995-1001 "http://rdf.glycoinfo.org/glycan/G81830JX" denotes GlcNAc
GlycanIUPAC_T175 1007-1010 "http://rdf.glycoinfo.org/glycan/G49112ZN" denotes Fuc
GlycanIUPAC_T176 1007-1010 "http://rdf.glycoinfo.org/glycan/G50059AJ" denotes Fuc
GlycanIUPAC_T177 1007-1010 "http://rdf.glycoinfo.org/glycan/G76218YK" denotes Fuc
GlycanIUPAC_T178 1007-1010 "http://rdf.glycoinfo.org/glycan/G50102KR" denotes Fuc
GlycanIUPAC_T179 1007-1010 "http://rdf.glycoinfo.org/glycan/G10717VS" denotes Fuc
GlycanIUPAC_T180 1007-1010 "http://rdf.glycoinfo.org/glycan/G60524RK" denotes Fuc
GlycanIUPAC_T181 1007-1010 "http://rdf.glycoinfo.org/glycan/G84407TT" denotes Fuc
GlycanIUPAC_T182 1007-1010 "http://rdf.glycoinfo.org/glycan/G64717JT" denotes Fuc
GlycanIUPAC_T183 1007-1010 "http://rdf.glycoinfo.org/glycan/G45003TT" denotes Fuc
GlycanIUPAC_T184 1007-1010 "http://rdf.glycoinfo.org/glycan/G73923FP" denotes Fuc
GlycanIUPAC_T185 1007-1010 "http://rdf.glycoinfo.org/glycan/G78231MB" denotes Fuc
GlycanIUPAC_T186 1007-1010 "http://rdf.glycoinfo.org/glycan/G80487UG" denotes Fuc
GlycanIUPAC_T187 1007-1010 "http://rdf.glycoinfo.org/glycan/G29758MI" denotes Fuc
GlycanIUPAC_T188 1007-1010 "http://rdf.glycoinfo.org/glycan/G02671KD" denotes Fuc
GlycanIUPAC_T189 1007-1010 "http://rdf.glycoinfo.org/glycan/G57926TZ" denotes Fuc
GlycanIUPAC_T190 1007-1010 "http://rdf.glycoinfo.org/glycan/G41718FD" denotes Fuc
GlycanIUPAC_T191 1007-1010 "http://rdf.glycoinfo.org/glycan/G99840FL" denotes Fuc
GlycanIUPAC_T192 1007-1010 "http://rdf.glycoinfo.org/glycan/G64321UX" denotes Fuc
GlycanIUPAC_T193 1007-1010 "http://rdf.glycoinfo.org/glycan/G11231EG" denotes Fuc
GlycanIUPAC_T194 1007-1010 "http://rdf.glycoinfo.org/glycan/G62741TN" denotes Fuc
GlycanIUPAC_T195 1007-1010 "http://rdf.glycoinfo.org/glycan/G51576ZQ" denotes Fuc
GlycanIUPAC_T196 1007-1010 "http://rdf.glycoinfo.org/glycan/G66056LD" denotes Fuc
GlycanIUPAC_T197 1007-1010 "http://rdf.glycoinfo.org/glycan/G02768BF" denotes Fuc
GlycanIUPAC_T198 1007-1010 "http://rdf.glycoinfo.org/glycan/G26168RO" denotes Fuc
GlycanIUPAC_T199 1007-1010 "http://rdf.glycoinfo.org/glycan/G42890HL" denotes Fuc
GlycanIUPAC_T200 1007-1010 "http://rdf.glycoinfo.org/glycan/G17533VU" denotes Fuc
GlycanIUPAC_T201 1007-1010 "http://rdf.glycoinfo.org/glycan/G34306RG" denotes Fuc
GlycanIUPAC_T202 1007-1010 "http://rdf.glycoinfo.org/glycan/G88735KU" denotes Fuc
GlycanIUPAC_T203 1007-1010 "http://rdf.glycoinfo.org/glycan/G82605UA" denotes Fuc

mondo_disease

Id Subject Object Predicate Lexical cue mondo_id
T1 487-490 Disease denotes OMD http://purl.obolibrary.org/obo/MONDO_0013316
T2 529-532 Disease denotes OMD http://purl.obolibrary.org/obo/MONDO_0013316
T3 642-647 Disease denotes MS. A http://purl.obolibrary.org/obo/MONDO_0007803|http://purl.obolibrary.org/obo/MONDO_0010892
T5 1323-1326 Disease denotes OMD http://purl.obolibrary.org/obo/MONDO_0013316
T6 1566-1587 Disease denotes inflammatory diseases http://purl.obolibrary.org/obo/MONDO_0021166

Glycan-GlyCosmos

Id Subject Object Predicate Lexical cue image
T1 21-36 Glycan denotes sialyl Lewis(x) https://api.glycosmos.org/wurcs2image/latest/png/binary/G00054MO
T2 227-242 Glycan denotes sialyl Lewis(x) https://api.glycosmos.org/wurcs2image/latest/png/binary/G00054MO
T3 504-519 Glycan denotes sialyl Lewis(x) https://api.glycosmos.org/wurcs2image/latest/png/binary/G00054MO
T4 727-742 Glycan denotes sialyl Lewis(x) https://api.glycosmos.org/wurcs2image/latest/png/binary/G00054MO
T5 983-988 Glycan denotes NeuAc https://api.glycosmos.org/wurcs2image/latest/png/binary/G76685HR
T6 1130-1145 Glycan denotes sialyl Lewis(x) https://api.glycosmos.org/wurcs2image/latest/png/binary/G00054MO
T7 1365-1380 Glycan denotes sialyl Lewis(x) https://api.glycosmos.org/wurcs2image/latest/png/binary/G00054MO
T8 1468-1483 Glycan denotes sialyl Lewis(x) https://api.glycosmos.org/wurcs2image/latest/png/binary/G00054MO

GlyCosmos-GlycoEpitope

Id Subject Object Predicate Lexical cue glycoepitope_id
T1 21-36 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes sialyl Lewis(x) http://www.glycoepitope.jp/epitopes/EP0012
T2 227-242 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes sialyl Lewis(x) http://www.glycoepitope.jp/epitopes/EP0012
T3 504-519 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes sialyl Lewis(x) http://www.glycoepitope.jp/epitopes/EP0012
T4 727-742 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes sialyl Lewis(x) http://www.glycoepitope.jp/epitopes/EP0012
T5 1130-1145 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes sialyl Lewis(x) http://www.glycoepitope.jp/epitopes/EP0012
T6 1365-1380 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes sialyl Lewis(x) http://www.glycoepitope.jp/epitopes/EP0012
T7 1468-1483 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes sialyl Lewis(x) http://www.glycoepitope.jp/epitopes/EP0012

GlyCosmos15-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T1 487-490 Disease denotes OMD http://purl.obolibrary.org/obo/MONDO_0013316
T2 529-532 Disease denotes OMD http://purl.obolibrary.org/obo/MONDO_0013316
T3 642-647 Disease denotes MS. A http://purl.obolibrary.org/obo/MONDO_0007803|http://purl.obolibrary.org/obo/MONDO_0010892
T5 1323-1326 Disease denotes OMD http://purl.obolibrary.org/obo/MONDO_0013316
T6 1566-1587 Disease denotes inflammatory diseases http://purl.obolibrary.org/obo/MONDO_0021166

GlyCosmos15-NCBITAXON

Id Subject Object Predicate Lexical cue db_id
T1 435-440 OrganismTaxon denotes human 9606

GlyCosmos15-UBERON

Id Subject Object Predicate Lexical cue uberon_id
T1 441-447 Body_part denotes plasma http://purl.obolibrary.org/obo/UBERON_0001969

sentences

Id Subject Object Predicate Lexical cue
TextSentencer_T1 0-146 Sentence denotes Site localization of sialyl Lewis(x) antigen on alpha1-acid glycoprotein by high performance liquid chromatography-electrospray mass spectrometry.
TextSentencer_T2 147-279 Sentence denotes A simple, fast and sensitive method was developed to verify the presence of the sialyl Lewis(x) antigen on an N-linked glycoprotein.
TextSentencer_T3 280-528 Sentence denotes High performance liquid chromatography-electrospray mass spectrometry (HPLC-ESI/MS) was used to identify which of the five N-linked glycosylation sites of human plasma alpha1-acid-glycoprotein (orosomucoid, OMD) contain the sialyl Lewis(x) antigen.
TextSentencer_T4 529-645 Sentence denotes OMD was digested with proteolytic enzymes and analyzed by reversed phase chromatography coupled with on-line ESI/MS.
TextSentencer_T5 646-885 Sentence denotes A tandem mass spectrometry experiment was designed to detect the presence of the sialyl Lewis(x) antigen based on the observation of an 803 mass to charge ratio ( m/z ) ion produced in the intermediate pressure region of the ESI interface.
TextSentencer_T6 886-1011 Sentence denotes The ESI/MS signal at m/z 803 is consistent with an oxonium ion for a glycan structure containing NeuAc, Gal, GlcNAc, and Fuc.
TextSentencer_T7 1012-1155 Sentence denotes The identity of the m/z 803 ion was confirmed by ESI/MS/MS analysis of the m/z 803 fragment ion and comparison with a sialyl Lewis(x) standard.
TextSentencer_T8 1156-1306 Sentence denotes The stereochemistry and linkage positions were assigned using previous NMR analysis but could be determined with permethylation analysis if necessary.
TextSentencer_T9 1307-1444 Sentence denotes The analysis of OMD gave a pattern showing signal for the sialyl Lewis(x) antigen coeluting with each of the five N-linked glycopeptides.
TextSentencer_T10 1445-1588 Sentence denotes The ability to monitor sialyl Lewis(x) expression at each of the five sites is of interest in the study of OMD's role in inflammatory diseases.
T1 0-146 Sentence denotes Site localization of sialyl Lewis(x) antigen on alpha1-acid glycoprotein by high performance liquid chromatography-electrospray mass spectrometry.
T2 147-279 Sentence denotes A simple, fast and sensitive method was developed to verify the presence of the sialyl Lewis(x) antigen on an N-linked glycoprotein.
T3 280-528 Sentence denotes High performance liquid chromatography-electrospray mass spectrometry (HPLC-ESI/MS) was used to identify which of the five N-linked glycosylation sites of human plasma alpha1-acid-glycoprotein (orosomucoid, OMD) contain the sialyl Lewis(x) antigen.
T4 529-645 Sentence denotes OMD was digested with proteolytic enzymes and analyzed by reversed phase chromatography coupled with on-line ESI/MS.
T5 646-885 Sentence denotes A tandem mass spectrometry experiment was designed to detect the presence of the sialyl Lewis(x) antigen based on the observation of an 803 mass to charge ratio ( m/z ) ion produced in the intermediate pressure region of the ESI interface.
T6 886-1155 Sentence denotes The ESI/MS signal at m/z 803 is consistent with an oxonium ion for a glycan structure containing NeuAc, Gal, GlcNAc, and Fuc. The identity of the m/z 803 ion was confirmed by ESI/MS/MS analysis of the m/z 803 fragment ion and comparison with a sialyl Lewis(x) standard.
T7 1156-1306 Sentence denotes The stereochemistry and linkage positions were assigned using previous NMR analysis but could be determined with permethylation analysis if necessary.
T8 1307-1444 Sentence denotes The analysis of OMD gave a pattern showing signal for the sialyl Lewis(x) antigen coeluting with each of the five N-linked glycopeptides.
T9 1445-1588 Sentence denotes The ability to monitor sialyl Lewis(x) expression at each of the five sites is of interest in the study of OMD's role in inflammatory diseases.
T1 0-146 Sentence denotes Site localization of sialyl Lewis(x) antigen on alpha1-acid glycoprotein by high performance liquid chromatography-electrospray mass spectrometry.
T2 147-279 Sentence denotes A simple, fast and sensitive method was developed to verify the presence of the sialyl Lewis(x) antigen on an N-linked glycoprotein.
T3 280-528 Sentence denotes High performance liquid chromatography-electrospray mass spectrometry (HPLC-ESI/MS) was used to identify which of the five N-linked glycosylation sites of human plasma alpha1-acid-glycoprotein (orosomucoid, OMD) contain the sialyl Lewis(x) antigen.
T4 529-645 Sentence denotes OMD was digested with proteolytic enzymes and analyzed by reversed phase chromatography coupled with on-line ESI/MS.
T5 646-885 Sentence denotes A tandem mass spectrometry experiment was designed to detect the presence of the sialyl Lewis(x) antigen based on the observation of an 803 mass to charge ratio ( m/z ) ion produced in the intermediate pressure region of the ESI interface.
T6 886-1011 Sentence denotes The ESI/MS signal at m/z 803 is consistent with an oxonium ion for a glycan structure containing NeuAc, Gal, GlcNAc, and Fuc.
T7 1012-1155 Sentence denotes The identity of the m/z 803 ion was confirmed by ESI/MS/MS analysis of the m/z 803 fragment ion and comparison with a sialyl Lewis(x) standard.
T8 1156-1306 Sentence denotes The stereochemistry and linkage positions were assigned using previous NMR analysis but could be determined with permethylation analysis if necessary.
T9 1307-1444 Sentence denotes The analysis of OMD gave a pattern showing signal for the sialyl Lewis(x) antigen coeluting with each of the five N-linked glycopeptides.
T10 1445-1588 Sentence denotes The ability to monitor sialyl Lewis(x) expression at each of the five sites is of interest in the study of OMD's role in inflammatory diseases.

GlyCosmos15-Sentences

Id Subject Object Predicate Lexical cue
T1 0-146 Sentence denotes Site localization of sialyl Lewis(x) antigen on alpha1-acid glycoprotein by high performance liquid chromatography-electrospray mass spectrometry.
T2 147-279 Sentence denotes A simple, fast and sensitive method was developed to verify the presence of the sialyl Lewis(x) antigen on an N-linked glycoprotein.
T3 280-528 Sentence denotes High performance liquid chromatography-electrospray mass spectrometry (HPLC-ESI/MS) was used to identify which of the five N-linked glycosylation sites of human plasma alpha1-acid-glycoprotein (orosomucoid, OMD) contain the sialyl Lewis(x) antigen.
T4 529-645 Sentence denotes OMD was digested with proteolytic enzymes and analyzed by reversed phase chromatography coupled with on-line ESI/MS.
T5 646-885 Sentence denotes A tandem mass spectrometry experiment was designed to detect the presence of the sialyl Lewis(x) antigen based on the observation of an 803 mass to charge ratio ( m/z ) ion produced in the intermediate pressure region of the ESI interface.
T6 886-1155 Sentence denotes The ESI/MS signal at m/z 803 is consistent with an oxonium ion for a glycan structure containing NeuAc, Gal, GlcNAc, and Fuc. The identity of the m/z 803 ion was confirmed by ESI/MS/MS analysis of the m/z 803 fragment ion and comparison with a sialyl Lewis(x) standard.
T7 1156-1306 Sentence denotes The stereochemistry and linkage positions were assigned using previous NMR analysis but could be determined with permethylation analysis if necessary.
T8 1307-1444 Sentence denotes The analysis of OMD gave a pattern showing signal for the sialyl Lewis(x) antigen coeluting with each of the five N-linked glycopeptides.
T9 1445-1588 Sentence denotes The ability to monitor sialyl Lewis(x) expression at each of the five sites is of interest in the study of OMD's role in inflammatory diseases.

GlyCosmos15-Glycan

Id Subject Object Predicate Lexical cue image
T1 21-36 Glycan denotes sialyl Lewis(x) https://api.glycosmos.org/wurcs2image/latest/png/binary/G00054MO
T2 227-242 Glycan denotes sialyl Lewis(x) https://api.glycosmos.org/wurcs2image/latest/png/binary/G00054MO
T3 504-519 Glycan denotes sialyl Lewis(x) https://api.glycosmos.org/wurcs2image/latest/png/binary/G00054MO
T4 727-742 Glycan denotes sialyl Lewis(x) https://api.glycosmos.org/wurcs2image/latest/png/binary/G00054MO
T5 983-988 Glycan denotes NeuAc https://api.glycosmos.org/wurcs2image/latest/png/binary/G76685HR
T6 1130-1145 Glycan denotes sialyl Lewis(x) https://api.glycosmos.org/wurcs2image/latest/png/binary/G00054MO
T7 1365-1380 Glycan denotes sialyl Lewis(x) https://api.glycosmos.org/wurcs2image/latest/png/binary/G00054MO
T8 1468-1483 Glycan denotes sialyl Lewis(x) https://api.glycosmos.org/wurcs2image/latest/png/binary/G00054MO

GlyCosmos15-GlycoEpitope

Id Subject Object Predicate Lexical cue glycoepitope_id
T1 21-36 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes sialyl Lewis(x) http://www.glycoepitope.jp/epitopes/EP0012
T2 227-242 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes sialyl Lewis(x) http://www.glycoepitope.jp/epitopes/EP0012
T3 504-519 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes sialyl Lewis(x) http://www.glycoepitope.jp/epitopes/EP0012
T4 727-742 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes sialyl Lewis(x) http://www.glycoepitope.jp/epitopes/EP0012
T5 1130-1145 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes sialyl Lewis(x) http://www.glycoepitope.jp/epitopes/EP0012
T6 1365-1380 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes sialyl Lewis(x) http://www.glycoepitope.jp/epitopes/EP0012
T7 1468-1483 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes sialyl Lewis(x) http://www.glycoepitope.jp/epitopes/EP0012

NCBITAXON

Id Subject Object Predicate Lexical cue db_id
T1 435-440 OrganismTaxon denotes human 9606

Anatomy-UBERON

Id Subject Object Predicate Lexical cue uberon_id
T1 441-447 Body_part denotes plasma http://purl.obolibrary.org/obo/UBERON_0001969